You are here
- Home
- Announcements
Announcements
-
UMOR Controlled Substances Monitoring Program Introduces Revised Escalation Plan
In an effort to further strengthen, safeguard, and support research at the University of Michigan, the U-M Office of Research (UMOR) Controlled Substances Monitoring Program has introduced a revised...Posted On: March 25, 2019 -
Propofol to Be Handled As Controlled Substance Effective August 1
Effective August 1, 2018, propofol will be handled and stored in the same manner as controlled substances. This change is applicable to all animal and analytical researchers across campus. To address...Posted On: June 29, 2018 -
National Drug Shortage: What You Should Know
There is a national shortage of several drugs commonly used in animals. These include the injectable opioid medications fentanyl, morphine, and hydromorphone, and other medications such as...Posted On: May 10, 2018 -
Updates to Guidelines on Anesthesia and Analgesia in Swine
The Guidelines on Anesthesia and Analgesia in Swine were updated on Friday, January 26. For your convenience, we have summarized key changes below:Posted On: February 5, 2018 -
Notice: Emergency Federal DEA Scheduling of All Non-Scheduled Fentanyl Analogs
The Federal Drug Enforcement Administration (DEA) has recently issued a Proposed Rule to temporarily place any non-scheduled ‘fentanyl-related’ substances (i.e., analogs) into Schedule I, effective...Posted On: January 29, 2018 -
Research Controlled Substances: State of Michigan and DEA Audit Preparedness
As an important reminder, the State of Michigan Department of Licensing and Regulatory Affairs (LARA) and the Federal Drug Enforcement Administration (DEA) can conduct unannounced inspections of...Posted On: January 22, 2018 -
Changes to State of Michigan Requirements for Annual Controlled Substances Inventory
Effective this year, the annual Controlled Substances Inventory required by the State of Michigan (SOM) to be completed betweenPosted On: May 25, 2017 -
Buprenorphine Recall – MWI (Animal Health Distributor)
Par Pharmaceutical is conducting a voluntary drug recall of specific lots of Buprenorphine HCI Injection 0.3mg/ml.Posted On: May 5, 2017 -
DEA Announces Changes in Registration Renewal Notifications
Starting in January 2017, the DEA will no longer be mailing a second renewal notification letter to controlled substance registrants. Registrants will now receive the second renewal reminder at the...Posted On: January 27, 2017 -
Changes to the Disposal Process for Schedules I and II Controlled Substances in Research
The U.S. Drug Enforcement Administration (DEA) has recently identified issues with documentation associated with the disposal procedures for Schedules I and II controlled substances used in research...Posted On: January 27, 2017
Pages
- « first
- ‹ previous
- 1
- 2
- 3
- 4